1h Free Analyst Time
The global thyroid gland disorder treatment market is forecasted to grow by USD 940.2 million during 2025-2030, accelerating at a CAGR of 5.1% during the forecast period. The report on the global thyroid gland disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by surging prevalence of autoimmune and chronic thyroid disorders, advancements in diagnostic infrastructure and public screening initiatives, technological progress in drug formulations and digital healthcare integration.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global thyroid gland disorder treatment market is segmented as below:
By Type
- Hypothyroidism
- Hyperthyroidism
By Distribution Channel
- Offline
- Online
By Route Of Administration
- Oral
- Intravenous
By Drug Class
- Hormone replacement therapies
- Anti-thyroid drugs
- Others
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global thyroid gland disorder treatment market covers the following areas:
- Global thyroid gland disorder treatment market sizing
- Global thyroid gland disorder treatment market forecast
- Global thyroid gland disorder treatment market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Thyroid Gland Disorder Treatment Market 2020 - 2024
- Historic Market Size - Data Table on Global Thyroid Gland Disorder Treatment Market 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global thyroid gland disorder treatment market
6.2 Impact of geopolitical conflicts on global thyroid gland disorder treatment market
6.2 Impact of geopolitical conflicts on global thyroid gland disorder treatment market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Hypothyroidism - Market size and forecast 2025-2030 ($ million)
- Data Table on Hypothyroidism - Market size and forecast 2025-2030 ($ million)
- Chart on Hypothyroidism - Year-over-year growth 2025-2030 (%)
- Data Table on Hypothyroidism - Year-over-year growth 2025-2030 (%)
- Chart on Hyperthyroidism - Market size and forecast 2025-2030 ($ million)
- Data Table on Hyperthyroidism - Market size and forecast 2025-2030 ($ million)
- Chart on Hyperthyroidism - Year-over-year growth 2025-2030 (%)
- Data Table on Hyperthyroidism - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Offline - Market size and forecast 2025-2030 ($ million)
- Data Table on Offline - Market size and forecast 2025-2030 ($ million)
- Chart on Offline - Year-over-year growth 2025-2030 (%)
- Data Table on Offline - Year-over-year growth 2025-2030 (%)
- Chart on Online - Market size and forecast 2025-2030 ($ million)
- Data Table on Online - Market size and forecast 2025-2030 ($ million)
- Chart on Online - Year-over-year growth 2025-2030 (%)
- Data Table on Online - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
- Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
- Chart on Intravenous - Year-over-year growth 2025-2030 (%)
- Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Market Segmentation by Drug Class
11.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Hormone replacement therapies - Market size and forecast 2025-2030 ($ million)
- Data Table on Hormone replacement therapies - Market size and forecast 2025-2030 ($ million)
- Chart on Hormone replacement therapies - Year-over-year growth 2025-2030 (%)
- Data Table on Hormone replacement therapies - Year-over-year growth 2025-2030 (%)
- Chart on Anti-thyroid drugs - Market size and forecast 2025-2030 ($ million)
- Data Table on Anti-thyroid drugs - Market size and forecast 2025-2030 ($ million)
- Chart on Anti-thyroid drugs - Year-over-year growth 2025-2030 (%)
- Data Table on Anti-thyroid drugs - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
12 Customer Landscape
12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Chile - Market size and forecast 2025-2030 ($ million)
- Data Table on Chile - Market size and forecast 2025-2030 ($ million)
- Chart on Chile - Year-over-year growth 2025-2030 (%)
- Data Table on Chile - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity
14.1 Market drivers
- Surging prevalence of autoimmune and chronic thyroid disorders
- Advancements in diagnostic infrastructure and public screening initiatives
- Technological progress in drug formulations and digital healthcare integration
- Stringent bioequivalence regulations and narrow therapeutic index limitations
- Supply chain vulnerabilities and frequent product recalls
- Diagnostic backlogs and low public awareness in emerging economies
- Impact of drivers and challenges in 2025 and 2030
- Proliferation of digital therapeutics and tele-endocrinology infrastructure
- Shift toward precision oncology and targeted multikinase inhibitor formulations
- Rising consumer integration of specialized nutraceuticals and preventative thyroid supplements
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
- SWOT
- Fresenius Kabi AG - Overview
- Fresenius Kabi AG - Product / Service
- Fresenius Kabi AG - Key offerings
- SWOT
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- SWOT
- IBSA Institut Biochimique SA - Overview
- IBSA Institut Biochimique SA - Product / Service
- IBSA Institut Biochimique SA - Key offerings
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Piramal Pharma Ltd. - Overview
- Piramal Pharma Ltd. - Business segments
- Piramal Pharma Ltd. - Key offerings
- Piramal Pharma Ltd. - Segment focus
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Takeda Pharmaceutical Ltd. - Overview
- Takeda Pharmaceutical Ltd. - Business segments
- Takeda Pharmaceutical Ltd. - Key news
- Takeda Pharmaceutical Ltd. - Key offerings
- Takeda Pharmaceutical Ltd. - Segment focus
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
17 Appendix
17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Thyroid Gland Disorder Treatment Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Type - Market share 2025-2030 (%)
Exhibit 41: Data Table on Type - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Type
Exhibit 43: Data Table on Comparison by Type
Exhibit 44: Chart on Hypothyroidism - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Hypothyroidism - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Hypothyroidism - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Hypothyroidism - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Hyperthyroidism - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Hyperthyroidism - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Hyperthyroidism - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Hyperthyroidism - Year-over-year growth 2025-2030 (%)
Exhibit 52: Market opportunity by Type ($ million)
Exhibit 53: Data Table on Market opportunity by Type ($ million)
Exhibit 54: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 55: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 56: Chart on Comparison by Distribution Channel
Exhibit 57: Data Table on Comparison by Distribution Channel
Exhibit 58: Chart on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 62: Chart on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 63: Data Table on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 64: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibit 65: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibit 66: Market opportunity by Distribution Channel ($ million)
Exhibit 67: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 68: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 69: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 70: Chart on Comparison by Route of Administration
Exhibit 71: Data Table on Comparison by Route of Administration
Exhibit 72: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 80: Market opportunity by Route of Administration ($ million)
Exhibit 81: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 82: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 83: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 84: Chart on Comparison by Drug Class
Exhibit 85: Data Table on Comparison by Drug Class
Exhibit 86: Chart on Hormone replacement therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Hormone replacement therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Hormone replacement therapies - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Hormone replacement therapies - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Anti-thyroid drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Anti-thyroid drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Anti-thyroid drugs - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Anti-thyroid drugs - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Drug Class ($ million)
Exhibit 99: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Regional Comparison - Asia
Exhibit 158: Data Table on Regional Comparison - Asia
Exhibit 159: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: AbbVie Inc. - Overview
Exhibit 231: AbbVie Inc. - Business segments
Exhibit 232: AbbVie Inc. - Key news
Exhibit 233: AbbVie Inc. - Key offerings
Exhibit 234: AbbVie Inc. - Segment focus
Exhibit 235: SWOT
Exhibit 236: Amneal Pharmaceuticals Inc. - Overview
Exhibit 237: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 238: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 239: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 240: SWOT
Exhibit 241: Bayer AG - Overview
Exhibit 242: Bayer AG - Business segments
Exhibit 243: Bayer AG - Key offerings
Exhibit 244: Bayer AG - Segment focus
Exhibit 245: SWOT
Exhibit 246: Eli Lilly and Co. - Overview
Exhibit 247: Eli Lilly and Co. - Product / Service
Exhibit 248: Eli Lilly and Co. - Key news
Exhibit 249: Eli Lilly and Co. - Key offerings
Exhibit 250: SWOT
Exhibit 251: Fresenius Kabi AG - Overview
Exhibit 252: Fresenius Kabi AG - Product / Service
Exhibit 253: Fresenius Kabi AG - Key offerings
Exhibit 254: SWOT
Exhibit 255: Hikma Pharmaceuticals Plc - Overview
Exhibit 256: Hikma Pharmaceuticals Plc - Business segments
Exhibit 257: Hikma Pharmaceuticals Plc - Key news
Exhibit 258: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 259: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 260: SWOT
Exhibit 261: IBSA Institut Biochimique SA - Overview
Exhibit 262: IBSA Institut Biochimique SA - Product / Service
Exhibit 263: IBSA Institut Biochimique SA - Key offerings
Exhibit 264: SWOT
Exhibit 265: Lupin Ltd. - Overview
Exhibit 266: Lupin Ltd. - Business segments
Exhibit 267: Lupin Ltd. - Key news
Exhibit 268: Lupin Ltd. - Key offerings
Exhibit 269: Lupin Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: Merck KGaA - Overview
Exhibit 272: Merck KGaA - Business segments
Exhibit 273: Merck KGaA - Key news
Exhibit 274: Merck KGaA - Key offerings
Exhibit 275: Merck KGaA - Segment focus
Exhibit 276: SWOT
Exhibit 277: Novartis AG - Overview
Exhibit 278: Novartis AG - Business segments
Exhibit 279: Novartis AG - Key news
Exhibit 280: Novartis AG - Key offerings
Exhibit 281: Novartis AG - Segment focus
Exhibit 282: SWOT
Exhibit 283: Pfizer Inc. - Overview
Exhibit 284: Pfizer Inc. - Business segments
Exhibit 285: Pfizer Inc. - Key news
Exhibit 286: Pfizer Inc. - Key offerings
Exhibit 287: Pfizer Inc. - Segment focus
Exhibit 288: SWOT
Exhibit 289: Piramal Pharma Ltd. - Overview
Exhibit 290: Piramal Pharma Ltd. - Business segments
Exhibit 291: Piramal Pharma Ltd. - Key offerings
Exhibit 292: Piramal Pharma Ltd. - Segment focus
Exhibit 293: SWOT
Exhibit 294: Sanofi SA - Overview
Exhibit 295: Sanofi SA - Business segments
Exhibit 296: Sanofi SA - Key news
Exhibit 297: Sanofi SA - Key offerings
Exhibit 298: Sanofi SA - Segment focus
Exhibit 299: SWOT
Exhibit 300: Takeda Pharmaceutical Ltd. - Overview
Exhibit 301: Takeda Pharmaceutical Ltd. - Business segments
Exhibit 302: Takeda Pharmaceutical Ltd. - Key news
Exhibit 303: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 304: Takeda Pharmaceutical Ltd. - Segment focus
Exhibit 305: SWOT
Exhibit 306: Viatris Inc. - Overview
Exhibit 307: Viatris Inc. - Business segments
Exhibit 308: Viatris Inc. - Key news
Exhibit 309: Viatris Inc. - Key offerings
Exhibit 310: Viatris Inc. - Segment focus
Exhibit 311: SWOT
Exhibit 312: Inclusions checklist
Exhibit 313: Exclusions checklist
Exhibit 314: Currency conversion rates for US$
Exhibit 315: Research methodology
Exhibit 316: Information sources
Exhibit 317: Data validation
Exhibit 318: Validation techniques employed for market sizing
Exhibit 319: Data synthesis
Exhibit 320: 360 degree market analysis
Exhibit 321: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Thyroid Gland Disorder Treatment Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Type - Market share 2025-2030 (%)
Exhibit 41: Data Table on Type - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Type
Exhibit 43: Data Table on Comparison by Type
Exhibit 44: Chart on Hypothyroidism - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Hypothyroidism - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Hypothyroidism - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Hypothyroidism - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Hyperthyroidism - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Hyperthyroidism - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Hyperthyroidism - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Hyperthyroidism - Year-over-year growth 2025-2030 (%)
Exhibit 52: Market opportunity by Type ($ million)
Exhibit 53: Data Table on Market opportunity by Type ($ million)
Exhibit 54: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 55: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 56: Chart on Comparison by Distribution Channel
Exhibit 57: Data Table on Comparison by Distribution Channel
Exhibit 58: Chart on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 62: Chart on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 63: Data Table on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 64: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibit 65: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibit 66: Market opportunity by Distribution Channel ($ million)
Exhibit 67: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 68: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 69: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 70: Chart on Comparison by Route of Administration
Exhibit 71: Data Table on Comparison by Route of Administration
Exhibit 72: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 80: Market opportunity by Route of Administration ($ million)
Exhibit 81: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 82: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 83: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 84: Chart on Comparison by Drug Class
Exhibit 85: Data Table on Comparison by Drug Class
Exhibit 86: Chart on Hormone replacement therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Hormone replacement therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Hormone replacement therapies - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Hormone replacement therapies - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Anti-thyroid drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Anti-thyroid drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Anti-thyroid drugs - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Anti-thyroid drugs - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Drug Class ($ million)
Exhibit 99: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Regional Comparison - Asia
Exhibit 158: Data Table on Regional Comparison - Asia
Exhibit 159: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: AbbVie Inc. - Overview
Exhibit 231: AbbVie Inc. - Business segments
Exhibit 232: AbbVie Inc. - Key news
Exhibit 233: AbbVie Inc. - Key offerings
Exhibit 234: AbbVie Inc. - Segment focus
Exhibit 235: SWOT
Exhibit 236: Amneal Pharmaceuticals Inc. - Overview
Exhibit 237: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 238: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 239: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 240: SWOT
Exhibit 241: Bayer AG - Overview
Exhibit 242: Bayer AG - Business segments
Exhibit 243: Bayer AG - Key offerings
Exhibit 244: Bayer AG - Segment focus
Exhibit 245: SWOT
Exhibit 246: Eli Lilly and Co. - Overview
Exhibit 247: Eli Lilly and Co. - Product / Service
Exhibit 248: Eli Lilly and Co. - Key news
Exhibit 249: Eli Lilly and Co. - Key offerings
Exhibit 250: SWOT
Exhibit 251: Fresenius Kabi AG - Overview
Exhibit 252: Fresenius Kabi AG - Product / Service
Exhibit 253: Fresenius Kabi AG - Key offerings
Exhibit 254: SWOT
Exhibit 255: Hikma Pharmaceuticals Plc - Overview
Exhibit 256: Hikma Pharmaceuticals Plc - Business segments
Exhibit 257: Hikma Pharmaceuticals Plc - Key news
Exhibit 258: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 259: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 260: SWOT
Exhibit 261: IBSA Institut Biochimique SA - Overview
Exhibit 262: IBSA Institut Biochimique SA - Product / Service
Exhibit 263: IBSA Institut Biochimique SA - Key offerings
Exhibit 264: SWOT
Exhibit 265: Lupin Ltd. - Overview
Exhibit 266: Lupin Ltd. - Business segments
Exhibit 267: Lupin Ltd. - Key news
Exhibit 268: Lupin Ltd. - Key offerings
Exhibit 269: Lupin Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: Merck KGaA - Overview
Exhibit 272: Merck KGaA - Business segments
Exhibit 273: Merck KGaA - Key news
Exhibit 274: Merck KGaA - Key offerings
Exhibit 275: Merck KGaA - Segment focus
Exhibit 276: SWOT
Exhibit 277: Novartis AG - Overview
Exhibit 278: Novartis AG - Business segments
Exhibit 279: Novartis AG - Key news
Exhibit 280: Novartis AG - Key offerings
Exhibit 281: Novartis AG - Segment focus
Exhibit 282: SWOT
Exhibit 283: Pfizer Inc. - Overview
Exhibit 284: Pfizer Inc. - Business segments
Exhibit 285: Pfizer Inc. - Key news
Exhibit 286: Pfizer Inc. - Key offerings
Exhibit 287: Pfizer Inc. - Segment focus
Exhibit 288: SWOT
Exhibit 289: Piramal Pharma Ltd. - Overview
Exhibit 290: Piramal Pharma Ltd. - Business segments
Exhibit 291: Piramal Pharma Ltd. - Key offerings
Exhibit 292: Piramal Pharma Ltd. - Segment focus
Exhibit 293: SWOT
Exhibit 294: Sanofi SA - Overview
Exhibit 295: Sanofi SA - Business segments
Exhibit 296: Sanofi SA - Key news
Exhibit 297: Sanofi SA - Key offerings
Exhibit 298: Sanofi SA - Segment focus
Exhibit 299: SWOT
Exhibit 300: Takeda Pharmaceutical Ltd. - Overview
Exhibit 301: Takeda Pharmaceutical Ltd. - Business segments
Exhibit 302: Takeda Pharmaceutical Ltd. - Key news
Exhibit 303: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 304: Takeda Pharmaceutical Ltd. - Segment focus
Exhibit 305: SWOT
Exhibit 306: Viatris Inc. - Overview
Exhibit 307: Viatris Inc. - Business segments
Exhibit 308: Viatris Inc. - Key news
Exhibit 309: Viatris Inc. - Key offerings
Exhibit 310: Viatris Inc. - Segment focus
Exhibit 311: SWOT
Exhibit 312: Inclusions checklist
Exhibit 313: Exclusions checklist
Exhibit 314: Currency conversion rates for US$
Exhibit 315: Research methodology
Exhibit 316: Information sources
Exhibit 317: Data validation
Exhibit 318: Validation techniques employed for market sizing
Exhibit 319: Data synthesis
Exhibit 320: 360 degree market analysis
Exhibit 321: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global thyroid gland disorder treatment market: Abbisko Therapeutics Co. Ltd., AbbVie Inc., Acella Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., ANI Pharmaceuticals Inc., Aspen Pharmacare Ltd., Bayer AG, Egetis Therapeutics AB, Eli Lilly and Co., Fresenius Kabi AG, Hikma Pharmaceuticals Plc, IBSA Institut Biochimique SA, Lupin Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Piramal Pharma Ltd., RLC Labs Inc., Sanofi SA, Takeda Pharmaceutical Ltd., Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is proliferation of digital therapeutics and tele-endocrinology infrastructure."
According to the report, one of the major drivers for this market is the surging prevalence of autoimmune and chronic thyroid disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbisko Therapeutics Co. Ltd.
- AbbVie Inc.
- Acella Pharmaceuticals LLC
- Amneal Pharmaceuticals Inc.
- ANI Pharmaceuticals Inc.
- Aspen Pharmacare Ltd.
- Bayer AG
- Egetis Therapeutics AB
- Eli Lilly and Co.
- Fresenius Kabi AG
- Hikma Pharmaceuticals Plc
- IBSA Institut Biochimique SA
- Lupin Ltd.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Piramal Pharma Ltd.
- RLC Labs Inc.
- Sanofi SA
- Takeda Pharmaceutical Ltd.
- Viatris Inc.
